Medical Comorbidities in Mecp2 Duplication Syndrome

Since the discovery of MECP2 duplication syndrome (MDS) in 1999, efforts to characterise this disorder have been limited by a lack of large datasets, with small case series often favouring the reporting of certain conditions over others. This study is the largest to date, featuring 134 males and 20 females, ascertained from the international MECP2 Duplication Database (MDBase). We report a higher frequency of pneumonia, bronchitis, bronchiolitis, gastroesophageal reflux and slow gut motility in males compared to females. We further examine the prevalence of other medical comorbidities such as epilepsy, gastrointestinal problems, feeding difficulties, scoliosis, bone fractures, sleep apnoea, autonomic disturbance and decreased pain sensitivity. A novel feature of urinary retention is reported and requires further investigation. Further research is required to understand the developmental trajectory of this disorder and to examine the context of these medical comorbidities in a quality of life framework

Bioinformatics · Biology · Comorbidity · Context (archaeology · Epilepsy · Gene duplication · Psychiatry · Congenital gastrointestinal and neural anomalies · Genetics and Neurodevelopmental Disorders · Medicine · Pediatric Hepatobiliary Diseases and Treatments · Genetics · Internal Medicine · Pediatrics

• How Families Manage the Complex Medical Needs of Their Children with Mecp2 Duplication Syndrome

  Open Access•Dani John Cherian, Daniel Ta et al.•Children•2023

  Incluir item

• Development of an International Database for a Rare Genetic Disorder

  Open Access•Daniel Ta, Jenny Downs et al.•Children•2022

  Incluir item

• Applied Survival Analysis

  Open Access•David W Hosmer, Stanley Lemeshow et al.•Applied Survival Analysis•2008

  Incluir item